These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 15386605)

  • 1. Preconceptions versus experience of transvaginal ultrasonography in older women.
    Kew FM; Whittaker VJ; Cruickshank DJ
    Ultrasound Obstet Gynecol; 2004 Oct; 24(5):572-4. PubMed ID: 15386605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tolerability of transvaginal ultrasonography as an ovarian cancer screening test.
    Kew FM; Ashton VJ; Cruickshank DJ
    J Med Screen; 2004; 11(1):45-7. PubMed ID: 15006114
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychological impact of screening for familial ovarian cancer.
    Wardle FJ; Collins W; Pernet AL; Whitehead MI; Bourne TH; Campbell S
    J Natl Cancer Inst; 1993 Apr; 85(8):653-7. PubMed ID: 8468723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mass-screening for ovarian cancer by means of transvaginal ultrasonography].
    Sato S; Hasuo Y; Ohta S; Maruyama H; Kagiya A; Saito Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Jun; 44(6):683-8. PubMed ID: 1506730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceptance of transvaginal sonography by postmenopausal women participating in the United Kingdom Collaborative Trial of Ovarian Cancer Screening.
    Gentry-Maharaj A; Sharma A; Burnell M; Ryan A; Amso NN; Seif MW; Turner G; Brunell C; Fletcher G; Rangar R; Fallowfield L; Campbell S; Jacobs I; Menon U
    Ultrasound Obstet Gynecol; 2013 Jan; 41(1):73-9. PubMed ID: 22791597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening transvaginal ultrasonography of postmenopausal women in a private office setting.
    Holbert TR
    Am J Obstet Gynecol; 1994 Jun; 170(6):1699-703; discussion 1703-4. PubMed ID: 8203429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian cancer screening in women with a family history of breast or ovarian cancer.
    Lacey JV; Greene MH; Buys SS; Reding D; Riley TL; Berg CD; Fagerstrom RM; Hartge P
    Obstet Gynecol; 2006 Nov; 108(5):1176-84. PubMed ID: 17077240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of transvaginal sonographic screening in asymptomatic women at risk for ovarian cancer.
    van Nagell JR; DePriest PD; Reedy MB; Gallion HH; Ueland FR; Pavlik EJ; Kryscio RJ
    Gynecol Oncol; 2000 Jun; 77(3):350-6. PubMed ID: 10831341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validity of self-reports of return for routine repeat screening in an ovarian cancer screening program.
    Lykins EL; Pavlik EL; Andrykowski MA
    Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):490-3. PubMed ID: 17372244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for ovarian cancer in the general population.
    Chu CS; Rubin SC
    Best Pract Res Clin Obstet Gynaecol; 2006 Apr; 20(2):307-20. PubMed ID: 16364690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three-dimensional ultrasonography and power Doppler in ovarian cancer screening of asymptomatic peri- and postmenopausal women.
    Kurjak A; Prka M; Arenas JM; Sparac V; Merce LT; Corusic A; Ivancic-Kosuta M
    Croat Med J; 2005 Oct; 46(5):757-64. PubMed ID: 16158468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transvaginal Sonography: perception and attitude of Nigerian women.
    Okeji MC; Agwuna KK; Ihudiebube-Splendor CN; Izge IY; Ekuma KK; Emeter JO
    BMC Womens Health; 2017 Jul; 17(1):54. PubMed ID: 28750613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Research in practice. Transvaginal screening.
    Kipps S
    Nurs Times; 1994 Jan 26-Feb 1; 90(4):44-8. PubMed ID: 8108260
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.
    Kobayashi H; Yamada Y; Sado T; Sakata M; Yoshida S; Kawaguchi R; Kanayama S; Shigetomi H; Haruta S; Tsuji Y; Ueda S; Kitanaka T; Oi H
    Gynecol Obstet Invest; 2008; 65(2):133-8. PubMed ID: 17957102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.
    Drescher CW; Nelson J; Peacock S; Andersen MR; McIntosh MW; Urban N
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):600-6. PubMed ID: 15066925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations in breast and colon cancer screening behavior in women.
    Carlos RC; Fendrick AM; Patterson SK; Bernstein SJ
    Acad Radiol; 2005 Apr; 12(4):451-8. PubMed ID: 15831418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Women at risk of ovarian cancer: attitudes towards and expectations of the familial ovarian cancer clinic.
    Sheppard R; Fry A; Rush R; Steel CM; Cull A
    Fam Cancer; 2001; 1(1):31-7. PubMed ID: 14574013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovarian cancer screening by transvaginal color Doppler ultrasonography.
    Rampone B; Rampone A; Tirabasso S; Panariello S; Rampone N
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):125-8. PubMed ID: 11526707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical, demographic, and psychological characteristics of new, asymptomatic participants in a transvaginal ultrasound screening program for ovarian cancer.
    Salsman JM; Pavlik E; Boerner LM; Andrykowski MA
    Prev Med; 2004 Aug; 39(2):315-22. PubMed ID: 15226040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attitudes of Colorado health professionals toward breast and cervical cancer screening in Hispanic women.
    Bakemeier RF; Krebs LU; Murphy JR; Shen Z; Ryals T
    J Natl Cancer Inst Monogr; 1995; (18):95-100. PubMed ID: 8562228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.